Enter assignee name

EPO Patents = 3

Trademarks = 1

Forward Citations = 1

Loading Chart...

10 inventors (with patents filed for the assignee):

Daniel Vitt (7 out of 13 patents)

Hella Kohlhof (7 out of 9 patents)

Andreas Mühler (6 out of 6 patents)

4. Manfred Gröppel (4 out of 4 patents)

5. Jakob Felding (1 out of 31 patents)

6. Manfred Groppel (1 out of 1 patent)

7. Rolf Andreas Muhler (1 out of 1 patent)

8. Carine Chevrier (1 out of 3 patents)

9. Stefan Tasler (1 out of 11 patents)

10. Mirko Zaja (1 out of 5 patents)

11. Rolf Andreas MÜHLER (0 patent)

7 patents: Sort by Forward Citations

1. 12433860 - Treatment of multiple sclerosis comprising DHODH inhibitors (2025-10-07),

2. 12167994 - Vidofludimus for use in the treatment or prevention of viral diseases (2024-12-17),

3. 12037305 - Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents (2024-07-16),

4. 11877995 - Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases (2024-01-23),

5. 11877994 - Treatment of multiple sclerosis comprising DHODH inhibitors (2024-01-23),

6. 11376232 - Vidofludimus for use in the treatment or prevention of viral diseases (2022-07-05),

7. 11292788 - IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation (2022-04-05),

Immunic AG is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. The company's lead program, IMU-838, is currently being evaluated in Phase 2 clinical trials for ulcerative colitis and relapsing-remitting multiple sclerosis.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

7 Patents

#1 in Gräfelfing

#4,804 in Germany

Gräfelfing, Germany

Immunic Ag